— Berlin Heals adds MedTech Veteran Dr. Eric Fain to Board of Directors — Dr. Fain brings over 35 years of strategic and start-up expertise — Extensive experience in the Cardiovascular space particularly in active implants — Led multiple successful financings and exits on both the strategic and start-up sides Berlin Heals Holding AG, a […]
ICIS, a leading source of commodity intelligence, and CPCIF, the leading national organization for China's petroleum and chemical industry, today released a new study shedding light on the impacts of the European Union's circularity regulation on global demand for recycled plastics, generally and China's chemical industries, in particular, with key implications across packaging, automotive, and
Winner to be crowned on October 29 All eyes will be on Milan on October 28 and 29 as theS.Pellegrino Young Chef Academy hosts its highly anticipated Competition Grand Finale. To view the Multimedia News Release, please click: https://www.multivu.com/s_pellegrino/9361951-en-world-famous-chefs-crown-next-global-gastronomy-star-grand-finale The culmination of the sixth edition of this global initiative follows two years of intense challenges
Huion officially releases the highly anticipated Kamvas Pro 24 (Gen 3) drawing display. This new model is designed for professional art communities, particularly those seeking a large-sized pen display with cutting-edge features, a natural pen experience, and sharp display quality. https://mma.prnewswire.com/media/2795367/Kamvas_Pro_24__Gen_3__2.jpg As Huion continues with its strategy of continuous development and responds to the rapid
Binance, the global blockchain company behind the world's largest cryptocurrency exchange by trading volume and users, today announced it is offering direct USD deposits and withdrawals for its users in over 70 countries. https://mma.prnewswire.com/media/2801578/image.jpg Through BPay Global-a Payments Service Provider licensed and regulated by the Central Bank of Bahrain, and part of the Binance Group-retail
Onco3R Therapeutics reports first pre-clinical data from its best-in-class precision oncology portfolio at the 2025 AACR-NCI-EORTC symposium GlobeNewswire October 22, 2025 Three posters to be presented featuring pre-clinical data of potential best-in-class FGFR3 selective inhibitor, SMARCA2 selective inhibitor, and P53 Y220C reactivator Candidates for FGFR3 and SMARCA2 programs identified: IND enabling studies anticipated in mid-2026
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — 17a-4's eDisclaimer and WebParser are being offered as a bundle from now through year end. This limited-time offer is designed to help firms enhance compliance, manage web content efficiently, and maximize their technology budgets as the calendar year draws to a close. 17a-4's eDisclaimer addresses the legal
Co-led by Forbion and Sofinnova Partners, along with founding investor Monograph Capital, and Weatherden Innovative lead program, ELV001, in-licensed by Elevara from Japan's Teijin Pharma with good tolerability and safety, plus early signs of efficacy in Phase 1b Disrupting the treatment paradigm for patients with incomplete response to Standard of Care (Methotrexate + Tumor Necrosis
Elevara Medicines Raises $70 Million Series A to Advance Phase 2 Rheumatoid Arthritis Trial and Expand Pipeline GlobeNewswire October 22, 2025 Co-led by Forbion and Sofinnova Partners, along with founding investor Monograph Capital, and Weatherden Innovative lead program, ELV001, in-licensed by Elevara from Japan's Teijin Pharma with good tolerability and safety, plus early signs of
17a-4 offers eDisclaimer and WebParser Bundle for End-of-Year Savings eDisclaimer is available with the usual end of year discounts and now WebParser can be included too. This new bundle helps clients streamline website and email disclaimer compliance. GlobeNewswire October 22, 2025 NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) — 17a-4's eDisclaimer and WebParser are being